SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+53.75%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$164M
AUM Growth
–
Cap. Flow
+$164M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
34.32%
Holding
81
New
81
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Vericel Corp
VCEL
|
$8.69M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.36M |
| 3 |
Delcath Systems
DCTH
|
$6.3M |
| 4 |
Insmed
INSM
|
$5.83M |
| 5 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$5.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 92.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vericel Corp
VCEL
$1.83B
| $8.69M | 5.05% | +281,346 | New | +$8.69M |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.36M | 3.7% | +200,000 | New | +$6.36M |
|
|
3
Delcath Systems
DCTH
$385M
| $6.3M | 3.66% | +351,616 | New | +$6.3M |
|
|
4
Insmed
INSM
$28.8B
| $5.83M | 3.38% | +175,000 | New | +$5.83M |
|
|
AMYT
5
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $5.7M | 3.31% | +402,556 | New | +$5.7M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.01M | 2.91% | +227,388 | New | +$5.01M |
|
7
Arvinas
ARVN
$568M
| $4.67M | 2.71% | +55,000 | New | +$4.67M |
|
8
Larimar Therapeutics
LRMR
$310M
| $4.65M | 2.7% | +217,203 | New | +$4.65M |
|
9
Immunovant
IMVT
$2.56B
| $4.62M | 2.68% | +100,000 | New | +$4.62M |
|
|
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.39M | 2.55% | +20,000 | New | +$4.39M |
|
11
Curis
CRIS
$20.9M
| $4.34M | 2.52% | +530,000 | New | +$4.34M |
|
12
Halozyme
HALO
$8.56B
| $4.27M | 2.48% | +100,000 | New | +$4.27M |
|
|
TCRR
13
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $4.21M | 2.44% | +136,000 | New | +$4.21M |
|
14
Sutro Biopharma
STRO
$72.7M
| $4.02M | 2.33% | +185,000 | New | +$4.02M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| $3.87M | 2.25% | +600,000 | New | +$3.87M |
|
16
ESSA Pharma
EPIX
$11.4M
| $3.85M | 2.24% | +322,917 | New | +$3.85M |
|
17
Cellectar Biosciences
CLRB
$15.5M
| $3.69M | 2.14% | +1,772,848 | New | +$3.69M |
|
|
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.33M | 1.93% | +53,766 | New | +$3.33M |
|
19
Kura Oncology
KURA
$686M
| $2.94M | 1.71% | +90,000 | New | +$2.94M |
|
20
Ascendis Pharma
ASND
$11.8B
| $2.93M | 1.7% | +17,556 | New | +$2.93M |
|
|
JNCE
21
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.85M | 1.65% | +406,665 | New | +$2.85M |
|
22
Evogene
EVGN
$10.9M
| $2.82M | 1.64% | +600,000 | New | +$2.82M |
|
23
Cogent Biosciences
COGT
$1.69B
| $2.64M | 1.53% | +235,066 | New | +$2.64M |
|
24
MoonLake Immunotherapeutics
MLTX
$3.54B
| $2.45M | 1.42% | +215,071 | New | +$2.45M |
|
25
Guardant Health
GH
$8.41B
| $2.43M | 1.41% | +18,825 | New | +$2.43M |
|